Login to Your Account

After IPO, Portola Seeks Seconds with $105.9M Public Offering

By Marie Powers
Staff Writer

Friday, October 18, 2013
Five months after closing its initial public offering (IPO), Portola Pharmaceuticals Inc. took advantage of the rise in its shares (NASDAQ:PTLA) to price an underwritten public offering of approximately 6.4 million shares of its common stock at $23.75 apiece.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription